Health-e News

U.S approves twice-yearly HIV prevention drug, but it’s unaffordable for countries most in need
Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.
This post U.S approves twice-yearly HIV prevention drug, but it’s unaffordable for countries most in need first appeared on Health-e News and is written by Yoliswa Sobuwa
